NCT01392508

IMproved PREdiction of Severe Sepsis in the Emergency Department

Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 759 (actual)
• Sponsor: Axis Shield Diagnostics Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used as a marker of severe sepsis (including septic shock) in patients presenting to the emergency department with suspected infection.

Conditions

• Systemic Inflammatory Response Syndrome (SIRS)
• Sepsis
• Severe Sepsis
• Septic Shock

Timeline

• Start date: 2011-03-01
• Primary completion: 2015-09-01
• Completion: 2015-09-01
• First posted: 2011-07-12
• Last updated: 2017-04-14

Locations

5 sites across 2 countries: United States, Sweden